Cargando…
Longitudinal assessment of brain-derived neurotrophic factor in Sardinian psychotic patients (LABSP): a protocol for a prospective observational study
INTRODUCTION: Brain-derived neurotrophic factor (BDNF) plays a crucial role in neurodevelopment, synaptic plasticity and neuronal function and survival. Serum and plasma BDNF levels are moderately, but consistently, decreased in patients with schizophrenia (SCZ) compared with healthy controls. There...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5729982/ https://www.ncbi.nlm.nih.gov/pubmed/28550022 http://dx.doi.org/10.1136/bmjopen-2016-014938 |
_version_ | 1783286277496373248 |
---|---|
author | Primavera, Diego Manchia, Mirko Deriu, Luca Tusconi, Massimo Collu, Roberto Scherma, Maria Fadda, Paola Fratta, Walter Carpiniello, Bernardo |
author_facet | Primavera, Diego Manchia, Mirko Deriu, Luca Tusconi, Massimo Collu, Roberto Scherma, Maria Fadda, Paola Fratta, Walter Carpiniello, Bernardo |
author_sort | Primavera, Diego |
collection | PubMed |
description | INTRODUCTION: Brain-derived neurotrophic factor (BDNF) plays a crucial role in neurodevelopment, synaptic plasticity and neuronal function and survival. Serum and plasma BDNF levels are moderately, but consistently, decreased in patients with schizophrenia (SCZ) compared with healthy controls. There is a lack of knowledge, however, on the temporal manifestation of this decline. Clinical, illness course and treatment factors might influence the variation of BDNF serum levels in patients with psychosis. In this context, we propose a longitudinal study of a cohort of SCZ and schizophrenic and schizoaffective disorder (SAD) Sardinian patients with the aim of disentangling the relationship between peripheral BDNF serum levels and changes of psychopathology, cognition and drug treatments. METHODS AND ANALYSIS: Longitudinal assessment of BDNF in Sardinian psychotic patients (LABSP) is a 24-month observational prospective cohort study. Patients with SAD will be recruited at the Psychiatry Research Unit of the Department of Medical Science and Public Health, University of Cagliari and University of Cagliari Health Agency, Cagliari, Italy. We will collect BDNF serum levels as well as sociodemographic, psychopathological and neurocognitive measures. Structured, semistructured and self-rating assessment tools, such as the Positive and Negative Syndrome Scale for psychopathological measures and the Brief Assessment of Cognition in Schizophrenia for cognitive function, will be used. ETHICS AND DISSEMINATION: This study protocol was approved by the University of Cagliari Health Agency Ethics Committee (NP2016/5491). The study will be conducted in accordance with the principles of good clinical practice, in the Declaration of Helsinki in compliance with the regulations. Participation will be voluntary and written informed consent will be obtained for each participant upon entry into the study. We plan to disseminate the results of our study through conference presentations and publication in international peer-reviewed journals. Access to raw data will be available in anonymised form upon request to the corresponding author. |
format | Online Article Text |
id | pubmed-5729982 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | BMJ Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-57299822017-12-19 Longitudinal assessment of brain-derived neurotrophic factor in Sardinian psychotic patients (LABSP): a protocol for a prospective observational study Primavera, Diego Manchia, Mirko Deriu, Luca Tusconi, Massimo Collu, Roberto Scherma, Maria Fadda, Paola Fratta, Walter Carpiniello, Bernardo BMJ Open Mental Health INTRODUCTION: Brain-derived neurotrophic factor (BDNF) plays a crucial role in neurodevelopment, synaptic plasticity and neuronal function and survival. Serum and plasma BDNF levels are moderately, but consistently, decreased in patients with schizophrenia (SCZ) compared with healthy controls. There is a lack of knowledge, however, on the temporal manifestation of this decline. Clinical, illness course and treatment factors might influence the variation of BDNF serum levels in patients with psychosis. In this context, we propose a longitudinal study of a cohort of SCZ and schizophrenic and schizoaffective disorder (SAD) Sardinian patients with the aim of disentangling the relationship between peripheral BDNF serum levels and changes of psychopathology, cognition and drug treatments. METHODS AND ANALYSIS: Longitudinal assessment of BDNF in Sardinian psychotic patients (LABSP) is a 24-month observational prospective cohort study. Patients with SAD will be recruited at the Psychiatry Research Unit of the Department of Medical Science and Public Health, University of Cagliari and University of Cagliari Health Agency, Cagliari, Italy. We will collect BDNF serum levels as well as sociodemographic, psychopathological and neurocognitive measures. Structured, semistructured and self-rating assessment tools, such as the Positive and Negative Syndrome Scale for psychopathological measures and the Brief Assessment of Cognition in Schizophrenia for cognitive function, will be used. ETHICS AND DISSEMINATION: This study protocol was approved by the University of Cagliari Health Agency Ethics Committee (NP2016/5491). The study will be conducted in accordance with the principles of good clinical practice, in the Declaration of Helsinki in compliance with the regulations. Participation will be voluntary and written informed consent will be obtained for each participant upon entry into the study. We plan to disseminate the results of our study through conference presentations and publication in international peer-reviewed journals. Access to raw data will be available in anonymised form upon request to the corresponding author. BMJ Publishing Group 2017-05-25 /pmc/articles/PMC5729982/ /pubmed/28550022 http://dx.doi.org/10.1136/bmjopen-2016-014938 Text en © Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2017. All rights reserved. No commercial use is permitted unless otherwise expressly granted. This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
spellingShingle | Mental Health Primavera, Diego Manchia, Mirko Deriu, Luca Tusconi, Massimo Collu, Roberto Scherma, Maria Fadda, Paola Fratta, Walter Carpiniello, Bernardo Longitudinal assessment of brain-derived neurotrophic factor in Sardinian psychotic patients (LABSP): a protocol for a prospective observational study |
title | Longitudinal assessment of brain-derived neurotrophic factor in Sardinian psychotic patients (LABSP): a protocol for a prospective observational study |
title_full | Longitudinal assessment of brain-derived neurotrophic factor in Sardinian psychotic patients (LABSP): a protocol for a prospective observational study |
title_fullStr | Longitudinal assessment of brain-derived neurotrophic factor in Sardinian psychotic patients (LABSP): a protocol for a prospective observational study |
title_full_unstemmed | Longitudinal assessment of brain-derived neurotrophic factor in Sardinian psychotic patients (LABSP): a protocol for a prospective observational study |
title_short | Longitudinal assessment of brain-derived neurotrophic factor in Sardinian psychotic patients (LABSP): a protocol for a prospective observational study |
title_sort | longitudinal assessment of brain-derived neurotrophic factor in sardinian psychotic patients (labsp): a protocol for a prospective observational study |
topic | Mental Health |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5729982/ https://www.ncbi.nlm.nih.gov/pubmed/28550022 http://dx.doi.org/10.1136/bmjopen-2016-014938 |
work_keys_str_mv | AT primaveradiego longitudinalassessmentofbrainderivedneurotrophicfactorinsardinianpsychoticpatientslabspaprotocolforaprospectiveobservationalstudy AT manchiamirko longitudinalassessmentofbrainderivedneurotrophicfactorinsardinianpsychoticpatientslabspaprotocolforaprospectiveobservationalstudy AT deriuluca longitudinalassessmentofbrainderivedneurotrophicfactorinsardinianpsychoticpatientslabspaprotocolforaprospectiveobservationalstudy AT tusconimassimo longitudinalassessmentofbrainderivedneurotrophicfactorinsardinianpsychoticpatientslabspaprotocolforaprospectiveobservationalstudy AT colluroberto longitudinalassessmentofbrainderivedneurotrophicfactorinsardinianpsychoticpatientslabspaprotocolforaprospectiveobservationalstudy AT schermamaria longitudinalassessmentofbrainderivedneurotrophicfactorinsardinianpsychoticpatientslabspaprotocolforaprospectiveobservationalstudy AT faddapaola longitudinalassessmentofbrainderivedneurotrophicfactorinsardinianpsychoticpatientslabspaprotocolforaprospectiveobservationalstudy AT frattawalter longitudinalassessmentofbrainderivedneurotrophicfactorinsardinianpsychoticpatientslabspaprotocolforaprospectiveobservationalstudy AT carpiniellobernardo longitudinalassessmentofbrainderivedneurotrophicfactorinsardinianpsychoticpatientslabspaprotocolforaprospectiveobservationalstudy |